Molecular Devices, JCR Pharmaceuticals deal

MDCC will acquire from JCR the 90 percent of Nihon Molecular Devices that it does not already own. Nihon Molecular, established by MDCC and JCR in 1995, is the Japanese distributor for MDCC's bioanaly...